Aurigene Pharmaceutical Services Limited vs WuXi AppTec

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/aurigeneservices/wuxiapptec

Category	Aurigene Pharmaceutical Services Limited	WuXi AppTec
Listed site	both	cro
Summary	Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.	Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Services	Discovery Research Target Identification & Validation Medicinal Chemistry High-Throughput Screening Computational & In-Silico Drug Discovery Protein Engineering	Discovery Research Target Identification & Validation High-Throughput Screening Medicinal Chemistry Computational & In-Silico Drug Discovery Protein Engineering Preclinical In Vitro Studies In Vitro Pharmacology In Vitro ADME / DMPK Safety Pharmacology Genetic Toxicology Preclinical In Vivo Studies In Vivo Efficacy Models In Vivo PK / PD Studies GLP Toxicology Carcinogenicity Studies DART (Reproductive & Developmental Toxicology) Specialized & Large-Animal Models Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Immunogenicity Assays (ADA / NAb) Biomarker Assays Flow Cytometry Services Clinical Trial Services Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Data Management & eClinical Biostatistics & Statistical Programming Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Analytical Method Development & Validation ICH Stability Studies Translational Research
Modalities	Small Molecule Biologics (Other) Peptide	Small Molecule Peptide Oligonucleotide Biologics (Monoclonal Antibodies) Biologics (Other) Antibody-Drug Conjugate (ADC) mRNA Cell Therapy Gene Therapy Vaccine
Indications	Data not yet provided.	Oncology Immunology Neurology Psychiatry Metabolic Cardiovascular Infectious Disease Rare Disease Respiratory Dermatology Ophthalmology Gastroenterology Nephrology Women's Health
Locations	Manufacturing - India, India Manufacturing - UK, United Kingdom Manufacturing - Mexico, Mexico	Headquarters, Shanghai, Pudong, China Global Operations, Asia, Europe, North America
Certifications	FDA · Identifier: 16 US FDA-inspected cGMP facilities	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.